These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32218847)

  • 1. BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
    Wang X; Xu Y; Xu K; Chen Y; Xiao X; Guan X
    Oncol Lett; 2020 Apr; 19(4):2916-2924. PubMed ID: 32218847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F; Luo N; Hu Y; Li X; Zhang K
    Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype.
    Angius A; Pira G; Cossu-Rocca P; Sotgiu G; Saderi L; Muroni MR; Virdis P; Piras D; Vincenzo R; Carru C; Coradduzza D; Uras MG; Cottu P; Fancellu A; Orrù S; Uva P; De Miglio MR
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3951-3963. PubMed ID: 36030436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZMIZ2 promotes the development of triple-receptor negative breast cancer.
    Zou X; Liu Y; Di J; Wei W; Watanabe N; Li J; Li X
    Cancer Cell Int; 2022 Jan; 22(1):52. PubMed ID: 35101047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.
    Chen B; Wei W; Huang X; Xie X; Kong Y; Dai D; Yang L; Wang J; Tang H; Xie X
    Theranostics; 2018; 8(14):4003-4015. PubMed ID: 30083277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.
    Khaled WT; Choon Lee S; Stingl J; Chen X; Raza Ali H; Rueda OM; Hadi F; Wang J; Yu Y; Chin SF; Stratton M; Futreal A; Jenkins NA; Aparicio S; Copeland NG; Watson CJ; Caldas C; Liu P
    Nat Commun; 2015 Jan; 6():5987. PubMed ID: 25574598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
    Riaz N; Idress R; Habib S; Lalani EN
    Front Oncol; 2020; 10():1083. PubMed ID: 32850312
    [No Abstract]   [Full Text] [Related]  

  • 10. The transcriptional repressor BCL11A promotes breast cancer metastasis.
    Seachrist DD; Hannigan MM; Ingles NN; Webb BM; Weber-Bonk KL; Yu P; Bebek G; Singh S; Sizemore ST; Varadan V; Licatalosi DD; Keri RA
    J Biol Chem; 2020 Aug; 295(33):11707-11719. PubMed ID: 32576660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer.
    Kucukzeybek BB; Bayoglu IV; Kucukzeybek Y; Yıldız Y; Oflazoglu U; Atahan MK; Taskaynatan H; Alacacioglu A; Yigit S; Tarhan MO
    Pol J Pathol; 2018; 69(2):157-168. PubMed ID: 30351863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
    Abd-Elazeem MA; Abd-Elazeem MA
    Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
    Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients.
    Medić-Milijić N; Jovanić I; Nedeljković M; Marković I; Spurnić I; Milovanović Z; Ademović N; Tomić T; Tanić N; Tanić N
    Life (Basel); 2024 May; 14(6):. PubMed ID: 38929666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells.
    Li S; Lee W; Heo W; Son HY; Her Y; Kim JI; Moon HG
    J Breast Cancer; 2023 Feb; 26(1):60-76. PubMed ID: 36762781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
    Choi JE; Kang SH; Lee SJ; Bae YK
    Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.
    Liu YX; Zhang KJ; Tang LL
    Oncol Lett; 2018 Jun; 15(6):10008-10016. PubMed ID: 29844843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.